Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,000 total articles
Chief Development Officer Christopher Yea recently sold shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) as part of a tax withholding process related to vested restricted stock units (RSUs). This transaction occurred while the company was also in the news for entering a merger agreement with Chiesi Group, valuing KALV at $1.9 billion.
Cohu's leadership sold a notable amount of stock recently, occurring while the company's shares have seen substantial gains. This transaction coincides with Q1 2026 financial results that showed mixed performance: exceeding revenue forecasts but failing to meet earnings per share expectations. Despite this initial stumble, Cohu provided an optimist…
Arista Networks director Kelly Battles executed a sale of company stock totaling $61,797 on May 21, 2026. This transaction occurred as Arista's share price continues to rise, reaching $158.01 and showing substantial growth over the past year. Despite the insider activity, recent financial reports indicate strong performance for Arista Networks, inc…
Paul K. Audhya, Chief Medical Officer at KalVista Pharmaceuticals, Inc., recently sold a block of common stock shares. This transaction was reportedly to cover tax obligations related to the settlement of restricted stock units (RSUs). The report details this sale in the context of the company's pending merger agreement with Chiesi Group, which val…
The Chief Financial Officer of KalVista Pharmaceuticals, Inc., Brian Piekos, recently completed a sale of company stock. This disposition was related to covering tax obligations arising from the vesting and settlement of restricted stock units (RSUs). These transactions occurred against a backdrop of significant corporate developments for KalVista,…
Director Kang Sun of Amprius Technologies, Inc. (NASDAQ:AMPX) executed a sale of common stock shares on May 21, 2026. The transaction was part of mandated 'sell-to-cover' arrangements used to fulfill tax withholding obligations from vested restricted stock units. In other corporate developments, the company reported its Q1 2026 earnings, noting a n…
A recent transaction involving COHU INC director James A. Donahue saw the sale of a significant block of company shares. This activity occurs as COHU stock trades near its 52-week peak and follows mixed first-quarter results, yet is buoyed by strong analyst upgrades citing growth in AI and high-performance computing test infrastructure.
The Chief Financial Officer of Pelthos Therapeutics Inc., Francis Knuettel II, reported selling a portion of his common stock. Concurrently, the company released its Q1 2026 earnings report, which revealed a significant shortfall in earnings per share (EPS). Despite this financial setback, PTHS saw an increase in its stock price, suggesting varied …
Richard Lee Van Kirk Jr., the Chief Executive Officer and Director at PRO DEX INC (NASDAQ:PDEX), recently reported selling company common stock. The total value of these transactions reached approximately $626,247. These sales transpired over two days, specifically May 21 and May 22, 2026.During this short period, Mr. Van Kirk Jr. disposed of a com…
A director of Hut 8 Corp. recently sold a significant block of company shares. This insider activity occurs while the stock is trading close to its 52-week high. The recent period also saw the company report an earnings miss for Q1 2026, countered by announcements of strategic infrastructure investments and positive coverage from Jefferies regardin…
Stefan Constantin Ionel, Chief Technology Officer at Amprius Technologies, Inc., sold $426,083 worth of common stock. This transaction occurred as the company's shares have experienced substantial gains over the past year, reaching a current trading price of $17.83. The article also details recent operational news, including Q1 2026 earnings that m…
Frank Porter Stansberry, a director and ten percent owner of MARKETWISE, INC. (NASDAQ:MKTW), recently purchased 10,000 shares of the company’s Class A Common Stock on May 22, 2026. This insider transaction occurred as MKTW stock has demonstrated notable market momentum, showing a 22% year-to-date gain and a 14% return over the past six months.The p…
Thomas M. Stepien, Chief Executive Officer of Amprius Technologies, Inc., executed a significant sale of company stock totaling approximately $897,685. This transaction occurred as part of mandated sell-to-cover arrangements related to vesting restricted stock units. The recent corporate activity includes reporting Q1 2026 earnings, announcing a pa…
Enphase Energy's CEO, Kothandaraman Badrinarayanan, recently purchased a substantial amount of the company's common stock. This transaction occurred as Enphase Energy (NASDAQ:ENPH) approached its 52-week high and following a sharp price increase over the last week. The report details the specifics of these purchases through a trust structure, while…
Managed funds associated with Maverick Capital have executed significant sales of common stock in Infleqtion, Inc. (NASDAQ:INFQ) over two days in May 2026. These combined transactions totaled approximately $186 million, involving multiple reporting owners and varied sale prices. The divestments occurred against a backdrop of strong recent share per…
The Chief Financial Officer of ESS Tech, Inc., conducted two separate transactions in May 2026, disposing of a total value of approximately $3,389 worth of common stock. These sales were attributed to covering tax withholding requirements related to the vesting of restricted stock units (RSUs). The timing of these sales occurred during a period of …
Kelly F. Goodman, Chief Strategy Officer and General Counsel at ESS Tech, Inc., conducted two recent stock sales totaling $4,849 worth of common stock in May 2026. These transactions were primarily linked to covering tax obligations associated with the vesting of restricted stock units (RSUs). Separately, ESS Tech reported its Q1 2026 earnings, not…
Jack Abuhoff, CEO and Director of Innodata Inc., recently executed stock option exercises followed by the sale of shares, totaling approximately $3.82 million. This transaction occurred against a backdrop of significant company growth, as Innodata shares have risen 163% over the past year. The report also details recent financial performance, notin…
Andrew R. Jassy, President and CEO of Amazon.com Inc., executed multiple transactions involving company common stock in May 2026. These sales were conducted under a pre-arranged trading plan, while the executive also acquired additional shares via vested Restricted Stock Units. Separately, recent corporate actions include Berkshire Hathaway's major…
Howard Wenger, President of Nextpower Inc., recently executed multiple stock sales. These transactions occurred alongside positive company developments, including strong financial results for the fourth quarter of fiscal 2026. The firm reported earnings per share of $1.05 and revenue of $881 million, surpassing analyst expectations. Furthermore, Ne…
The article details insider trading activity involving AWS CEO Matthew Garman, noting a significant divestment of company stock under a predetermined trading plan. It also outlines his simultaneous acquisition of shares through restricted stock unit vesting. Furthermore, the piece provides context on Amazon's broader corporate strategy, including e…
Senior Vice President and CTO Steven Weiskircher reported significant transactions involving Liquidity Services Inc.'s common stock through an SEC Form 4 filing. These filings detailed the sale of approximately $409,890 worth of shares and simultaneous acquisitions via option exercises. The article also provides context on recent company financial …
GE HealthCare director Kevin Lobo purchased shares totaling $641,800 on May 22, 2026. This activity occurs while the company's stock trades near its 52-week low, following a period of mixed operational news and varied analyst recommendations regarding its valuation and future prospects. The firm reported first-quarter revenues slightly above consen…
Hyatt Hotels director Cary McMillan sold a significant block of company stock in May 2026. This transaction occurred against a backdrop of mixed first-quarter results for the corporation, which beat earnings estimates but slightly underperformed revenue forecasts. Separately, other market developments include Hydro One Inc.'s bond offering and divi…
Director Susan D. Kronick sold 1,119 shares of Hyatt Hotels Corp's Class A Common Stock totaling $195,280 on May 22, 2026. The sale was conducted under a Rule 10b5-1 trading plan. This activity occurred as the stock trades near its 52-week high and recent financial reports showed mixed results, including exceeding EPS expectations but slightly miss…
